First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pharmacy and Science

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.22568PMID 21484808PMCID PMC3409645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Absorption Studies: In Situ, In Vitro and In Silico Models

  2021cited by this paper
• Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases

  2011cited by this paper
• Three-Dimensional Quantitative Structure-Activity Relationship Studies on UGT1A9-Mediated 3-O-Glucuronidation of Natural Flavonols Using a Pharmacophore-Based Comparative Molecular Field Analysis Model

  2011cited by this paper
• Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.

  2010cited by this paper
• Insights on membrane topology and structure/function of UDP-glucuronosyltransferases

  2010cited by this paper
• Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.

  2010cited by this paper
• Sex Differences in UDP-Glucuronosyltransferase 2B17 Expression and Activity

  2010cited by this paper
• Species and Gender Differences Affect the Metabolism of Emodin via Glucuronidation

  2010cited by this paper
• Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

  2010cited by this paper
• Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes

  2010cited by this paper
• Breast Cancer Resistance Protein (BCRP) and Sulfotransferases Contribute Significantly to the Disposition of Genistein in Mouse Intestine

  2010cited by this paper
• Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol.

  2010cited by this paper
• Bioavailability challenges associated with development of anti-cancer phenolics.

  2010cited by this paper
• Identification of the Human UDP-Glucuronosyltransferases Involved in the Glucuronidation of Combretastatin A-4

  2010cited by this paper
• A Molecular Model of the Human UDP-Glucuronosyltransferase 1A1, Its Membrane Orientation, and the Interactions between Different Parts of the Enzyme

  2010cited by this paper
• Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects

  2010cited by this paper
• Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10

  2010cited by this paper
• How Many and Which Amino Acids Are Responsible for the Large Activity Differences between the Highly Homologous UDP-Glucuronosyltransferases (UGT) 1A9 and UGT1A10?

  2010cited by this paper
• Identification and Characterization of Human UDP-Glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Daphnetin

  2010cited by this paper
• The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families

  2010cited by this paper
• In Vitro–In Vivo Extrapolation Predicts Drug–Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans

  2010cited by this paper
• Phase II Metabolism of Hesperetin by Individual UDP-Glucuronosyltransferases and Sulfotransferases and Rat and Human Tissue Samples

  2010cited by this paper
• Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug–drug interactions between PKC inhibitors and UGT1A6

  2010cited by this paper
• Glucuronidation of Dihydrotestosterone and trans-Androsterone by Recombinant UDP-Glucuronosyltransferase (UGT) 1A4: Evidence for Multiple UGT1A4 Aglycone Binding Sites

  2010cited by this paper
• Resveratrol bioavailability and toxicity in humans.

  2010cited by this paper
• Pharmacogenetics of irinotecan disposition and toxicity: a review.

  2010cited by this paper
• Regulated Phosphorylation of a Major UDP-glucuronosyltransferase Isozyme by Tyrosine Kinases Dictates Endogenous Substrate Selection for Detoxification*

  2010cited by this paper
• The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

  2010cited by this paper
• Dietary phenolics: chemistry, bioavailability and effects on health.

  2009cited by this paper
• AVE8062: a new combretastatin derivative vascular disrupting agent

  2009cited by this paper
• Sex-Dependent Disposition of Acetaminophen Sulfate and Glucuronide in the in Situ Perfused Mouse Liver

  2009cited by this paper
• Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

  2009cited by this paper
• Crystal structures of glycosyltransferase UGT78G1 reveal the molecular basis for glycosylation and deglycosylation of (iso)flavonoids.

  2009cited by this paper
• Substrate specificity of plant UDP-dependent glycosyltransferases predicted from crystal structures and homology modeling.

  2009cited by this paper
• Structure–activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases

  2009cited by this paper
• Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats.

  2009cited by this paper
• Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

  2009cited by this paper
• Src supports UDP-glucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancer.

  2009cited by this paper
• Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers

  2009cited by this paper
• The role of pH in the glucuronidation of raloxifene, mycophenolic acid and ezetimibe.

  2009cited by this paper
• In silico and in vitro approaches to elucidate the thermal stability of human UDP-glucuronosyltransferase (UGT) 1A9.

  2009cited by this paper
• Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.

  2009cited by this paper
• Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.

  2009cited by this paper
• Influence of N-Terminal Domain Histidine and Proline Residues on the Substrate Selectivities of Human UDP-Glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10

  2009cited by this paper
• Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.

  2009cited by this paper
• Absorption, Conjugation and Efflux of the Flavonoids, Kaempferol and Galangin, Using the Intestinal CACO-2/TC7 Cell Model.

  2009cited by this paper
• Disposition of Flavonoids via Enteric Recycling: UDP-Glucuronosyltransferase (UGT) 1As Deficiency in Gunn Rats Is Compensated by Increases in UGT2Bs Activities

  2009cited by this paper
• Influence of N-Terminal Domain Histidine and Proline Residues on the Substrate Selectivities of Human UDP-Glucuronosyltransferase 1 A 1 , 1 A 6 , 1 A 9 , 2 B 7 , and 2 B 10

  2009cited by this paper
• Intestinal first-pass glucuronidation activities of selected dihydroxyflavones.

  2009cited by this paper
• Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.

  2009cited by this paper
• Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.

  2008cited by this paper
• Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers

  2008cited by this paper
• Pharmacokinetic Study of Noni Fruit Extract

  2008cited by this paper
• Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.

  2008cited by this paper
• Activation of EpRE-mediated gene transcription by quercetin glucuronides depends on their deconjugation.

  2008cited by this paper
• Morphine-6-glucuronide: potency and safety compared with morphine

  2008cited by this paper
• Effect of intestinal glucuronidation in limiting hepatic exposure and bioactivation of raloxifene in humans and rats.

  2008cited by this paper
• The UDP-glucuronosyltransferases as oligomeric enzymes.

  2008cited by this paper
• Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain.

  2008cited by this paper
• Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines

  2008cited by this paper
• The Major Chemical-detoxifying System of UDP-glucuronosyltransferases Requires Regulated Phosphorylation Supported by Protein Kinase C*

  2008cited by this paper
• Contribution of UDP-Glucuronosyltransferase 1A1 and 1A8 to Morphine-6-Glucuronidation and Its Kinetic Properties

  2008cited by this paper
• A Catenary Model to Study Transport and Conjugation of Baicalein, a Bioactive Flavonoid, in the Caco-2 Cell Monolayer: Demonstration of Substrate Inhibition

  2008cited by this paper
• Regioselectivity of human UDP-glucuronosyl-transferase 1A1 in the synthesis of flavonoid glucuronides determined by metal complexation and tandem mass spectrometry

  2008cited by this paper
• Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion.

  2008cited by this paper
• Drug Absorption Studies

  2008cited by this paper
• Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.

  2007cited by this paper
• Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes

  2007cited by this paper
• Elimination of Antiestrogenic Effects of Active Tamoxifen Metabolites by Glucuronidation

  2007cited by this paper
• Crystal structure of Medicago truncatula UGT85H2--insights into the structural basis of a multifunctional (iso)flavonoid glycosyltransferase.

  2007cited by this paper
• Natural polyphenol disposition via coupled metabolic pathways

  2007cited by this paper
• Therapeutic opportunities in colon-specific drug-delivery systems.

  2007cited by this paper
• The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

  2007cited by this paper
• Glucuronidation of Active Tamoxifen Metabolites by the Human UDP Glucuronosyltransferases

  2007cited by this paper
• Substrate specificity of the human UDP‐glucuronosyltransferase UGT2B4 and UGT2B7

  2007cited by this paper
• Commentary: bioavailability of flavonoids and polyphenols: call to arms.

  2007cited by this paper
• Cholesterol-Lowering Effect of Ezetimibe in Uridine Diphosphate Glucuronosyltransferase 1A-Deficient (Gunn) Rats

  2007cited by this paper
• Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells.

  2007cited by this paper
• Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity

  2007cited by this paper
• Intestinal and hepatic glucuronidation of flavonoids.

  2007cited by this paper
• Characterization and engineering of the bifunctional N- and O-glucosyltransferase involved in xenobiotic metabolism in plants

  2007cited by this paper
• Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.

  2007cited by this paper
• Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10.

  2007cited by this paper
• Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties

  2007cited by this paper
• Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry.

  2007cited by this paper
• Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.

  2007cited by this paper
• Mechanistic study on the intestinal absorption and disposition of baicalein.

  2007cited by this paper
• Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA.

  2007cited by this paper
• Comparative modelling of the human UDP-glucuronosyltransferases: Insights into structure and mechanism

  2007cited by this paper
• Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent

  2007cited by this paper
• Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

  2007cited by this paper
• Tissue- and Gender-Specific mRNA Expression of UDP-Glucuronosyltransferases (UGTs) in Mice

  2007cited by this paper
• LC/MS/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma.

  2006cited by this paper
• Glycosyltransferases of lipophilic small molecules.

  2006cited by this paper
• Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties

  2006cited by this paper
• Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability

  2006cited by this paper
• Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.

  2006cited by this paper
• Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat

  2006cited by this paper
• Metabolism of green tea catechins: an overview.

  2006cited by this paper
• Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants

  2006cited by this paper

• Advancing infection therapy: the role of novel menthol-based antimicrobials

  2026cites this paper
• Biological effects of chlorogenic acid nanoformulations on colorectal cancer cells

  2025cites this paper
• Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications

  2025cites this paper
• In silico metabolite profiling and molecular simulation of scopoletin derivatives as CYP3A4 modulators: a pharmacometabolomic strategy against aflatoxin B1 bioactivation

  2025cites this paper
• The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review.

  2025cites this paper
• Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer

  2025cites this paper
• Piceatannol: a multifaceted polyphenol—from pharmacological actions to formulation development and clinical trials

  2025cites this paper
• From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy

  2025cites this paper
• Crocetin as a Neuroprotective Agent: Targeting Western Diet-Induced Cognitive Dysfunction Through Antioxidant, Anti-Inflammatory and Gut-Brain Axis Modulation

  2025cites this paper
• Curcumin as a modulator of drug metabolism and gene expression: Implications for pharmacogenomics

  2025cites this paper
• Advancing Predictions of Oral Drug Absorption, CYP3A4 Induction, and Transporter‐Mediated Interactions Using a Human Primary Intestinal 3D Model (EpiIntestinal™)

  2025cites this paper
• Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors.

  2025cites this paper
• Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation

  2025cites this paper
• Phenol (bio)isosteres in drug design and development

  2024cites this paper
• Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy

  2024cites this paper
• The potential role of luteolin, a flavonoid in cancer prevention and treatment

  2024cites this paper
• Functional chewing gum: Transition from a conventional chew to a novel matrix delivering encapsulated bioactives with health-promoting properties

  2024cites this paper
• Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery

  2024cites this paper
• Piperine Enhances Antimalarial Activity of Methyl Gallate and Palmatine Combination

  2024cites this paper
• Consumption of Plant-Derived Phenolic Acids Modulates Hunger and Satiety Responses Due to Chemical Interactions with Enteroendocrine Mediators

  2024cites this paper
• Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy

  2024cites this paper
• The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review

  2024cites this paper
• The Role of UDP-Glycosyltransferases in Xenobiotic Metabolism

  2024influential citation
• Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece

  2024cites this paper
• How do in vitro digestion and cell metabolism affect the biological activity and phenolic profile of grape juice and wine.

  2024cites this paper
• Similarities in Structure and Function of UDP-Glycosyltransferase Homologs from Human and Plants

  2024cites this paper
• 50th Anniversary Celebration Collection Special Section on New and Emerging Areas and Technologies in Drug Metabolism and Disposition, Part I Identification of a Discrete Diglucuronide of GDC-0810 in Human Plasma after Oral Administration S

  2023cites this paper
• Diet and Aging: The Role of Polyphenol-Rich Diets in Slow Down the Shortening of Telomeres: A Review

  2023cites this paper
• Optimized solubility and bioavailability of genistein based on cocrystal engineering

  2023cites this paper
• Identification of a Discrete Diglucuronide of GDC-0810 in Human Plasma after Oral Administration

  2023cites this paper
• Semi-synthesis of phenolic-amides and their cytotoxicity against THP-1, HeLa, HepG2 and MCF-7 cell lines

  2023cites this paper
• Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer.

  2023cites this paper
• SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer.

  2023cites this paper
• Antioxidant Activity, Metabolism, and Bioavailability of Polyphenols in the Diet of Animals

  2023influential citation
• Formulation and Characterization of Phytosomes as Drug Delivery System of Formononetin: An effective Anti-Osteoporotic Agent.

  2023cites this paper
• Ameliorated antioxidant and phytochemical profiling of Canscora decussata – An ayurvedic medicinal plant

  2023cites this paper
• In Vitro and In Silico Study on the Impact of Chlorogenic Acid in Colorectal Cancer Cells: Proliferation, Apoptosis, and Interaction with β-Catenin and LRP6

  2023cites this paper
• Fabrication of luteolin loaded zein-caseinate nanoparticles and its bioavailability enhancement in rats.

  2023cites this paper
• Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science

  2023cites this paper
• Dietary Polyphenols as a Protection against Cognitive Decline: Evidence from Animal Experiments; Mechanisms and Limitations

  2023cites this paper
• Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases

  2022cites this paper
• HPLC and HPLC-MS Analysis of Intestinal Elimination and Phase 2 Metabolism of 4'-hydroxy-4-Methoxychalcone and its Bis-Mannich Analog In The Rat

  2022cites this paper
• Identification of Cannabidivarin Metabolites in Different Mouse Organs Using Ultra-Performance Liquid Chromatography Coupled to a Quadrupole Time-of-Flight Mass Spectrometer

  2022cites this paper
• Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS

  2022cites this paper
• Polyphenols in Ruminant Nutrition and Their Effects on Reproduction

  2022cites this paper
• Species-dependent hepatic and intestinal metabolism of selective oestrogen receptor degrader LSZ102 by sulphation and glucuronidation

  2022cites this paper
• Effect of Crushing Peanuts on Fatty Acid and Phenolic Bioaccessibility: A Long-Term Study

  2022cites this paper
• The essence of male scent promotes female puberty and estrus

  2022cites this paper
• Modulatory Effect of Chlorogenic Acid and Coffee Extracts on Wnt/β-Catenin Pathway in Colorectal Cancer Cells

  2022cites this paper
• Characterizing and Quantifying Extrahepatic Metabolism of (−)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC)

  2022cites this paper
• Discovery of novel 2H-chromene-3-carbonyl derivatives as selective estrogen receptor degraders (SERDs): Design, synthesis and biological evaluation.

  2021cites this paper
• Acylated anthocyanins: A review on their bioavailability and effects on postprandial carbohydrate metabolism and inflammation.

  2021cites this paper
• Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase–Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell–Derived Small Intestinal Epithelial Cells

  2021cites this paper
• PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5′-Diphospho-glucuronosyltransferase Substrates

  2021cites this paper
• A highly selective fluorescent probe for real-time imaging of UDP-glucuronosyltransferase 1A8 in living cells and tissues

  2021cites this paper
• Contribution of Biotransformations Carried Out by the Microbiota, Drug-Metabolizing Enzymes, and Transport Proteins to the Biological Activities of Phytochemicals Found in the Diet.

  2021cites this paper
• Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents

  2021cites this paper
• Navigating Calcium and Reactive Oxygen Species by Natural Flavones for the Treatment of Heart Failure

  2021cites this paper
• Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties

  2021cites this paper
• Potential determinants for metabolic fates and inhibitory effects of isobavachalcone involving in human cytochrome P450, UDP-glucuronosyltransferase enzymes, and efflux transporters.

  2021cites this paper
• Identification of human uridine diphosphate-glucuronosyltransferase isoforms responsible for the glucuronidation of 10,11-dihydro-10-hydroxy-carbazepine.

  2021cites this paper
• Stratification of Volunteers According to Flavanone Metabolite Excretion and Phase II Metabolism Profile after Single Doses of ‘Pera’ Orange and ‘Moro’ Blood Orange Juices

  2021cites this paper
• The Chemistry of Cannabis and Cannabinoids

  2021cites this paper
• Metabolism of Phenolics of Tetrastigma hemsleyanum Roots under In Vitro Digestion and Colonic Fermentation as Well as Their In Vivo Antioxidant Activity in Rats

  2021cites this paper
• In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver

  2021cites this paper
• Disposition of Bisphenol S metabolites in Sprague-Dawley rats.

  2021cites this paper
• Pharmacokinetics and Biodistribution of Eriocitrin in Rats.

  2021cites this paper
• Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer.

  2020cites this paper
• Flavonols and Flavones

  2020cites this paper
• Bioavailability and Nutritional Analysis of Flavonoids

  2020cites this paper
• Homology Modeling of Human Uridine-5′-diphosphate-glucuronosyltransferase 1A6 Reveals Insights into Factors Influencing Substrate and Cosubstrate Binding

  2020cites this paper
• Curcuma longa L. (Zingiberaceae): desenvolvimento tecnológico para aplicação como agente terapêutico auxiliar no tratamento de pacientes portadores da Doença de Alzheimer

  2020cites this paper
• Blueberry Consumption Challenges Hepatic Mitochondrial Bioenergetics and Elicits Transcriptomics Reprogramming in Healthy Wistar Rats

  2020cites this paper
• Metabolism and Pharmacokinetics of Phytochemicals in the Human Body.

  2020cites this paper
• Polyphenols in Urine and Cardiovascular Risk Factors: A Cross-Sectional Analysis Reveals Gender Differences in Spanish Adolescents from the SI! Program

  2020cites this paper
• Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells

  2020cites this paper
• In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes

  2020cites this paper
• Unveiling the Impact of Morphine on Tamoxifen Metabolism in Mice in vivo

  2020cites this paper
• Liver background uptake of [18F]FLT in PET imaging.

  2020cites this paper
• Potential metabolism determinants and drug–drug interactions of a natural flavanone bavachinin

  2020cites this paper
• Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist

  2020cites this paper
• Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer.

  2020cites this paper
• Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity

  2020cites this paper
• The Impact of Dietary Supplementation of Whole Foods and Polyphenols on Atherosclerosis

  2020cites this paper
• Pharmacogenomics and Psychopharmacology

  2020cites this paper
• Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu‐gu‐zhi) and its potential inhibition against human cytochrome P450s and UDP‐glucuronosyltransferases

  2020influential citation
• Sulfation predominates the pharmacokinetics, metabolism, and excretion of forsythin in humans: major enzymes and transporters identified

  2020cites this paper
• Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt.

  2020cites this paper
• Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma.

  2020cites this paper
• In-Depth Characterization of EpiIntestinal Microtissue as a Model for Intestinal Drug Absorption and Metabolism in Human

  2020influential citation
• Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

  2020cites this paper
• Thermal and non-thermal processing of red-fleshed apple: how are (poly)phenol composition and bioavailability affected?

  2020cites this paper
• Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks

  2020influential citation
• Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine

  2020cites this paper
• The Effects of Flavonoids in Cardiovascular Diseases

  2020cites this paper
• Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines

  2019cites this paper
• A Review of Factors Affecting Anthocyanin Bioavailability: Possible Implications for the Inter-Individual Variability

  2019cites this paper
• Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity

  2019cites this paper
• Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome.

  2019cites this paper
• French and Mediterranean-style diets: Contradictions, misconceptions and scientific facts-A review.

  2019cites this paper